Suchergebnisse - "Gillot, Constant"

PubPharm (9)

1

Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Simon, G. | Favresse, J. | Gillot, C. | +6

2

Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals : importance of the timing

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Gillot, C. | Bayart, J. | Closset, M. | +5

3

Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster

enthalten in: Journal of medical virology | 2023

von Favresse, J. | Gillot, C. | Bayart, J. | +6

4

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination

enthalten in: Viruses | 2022

von Catry, E. | Favresse, J. | Gillot, C. | +8

5

Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Favresse, J. | Bayart, J. | David, C. | +4

6

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects

enthalten in: Viruses | 2021

von Gillot, C. | Favresse, J. | Maloteau, V. | +2

7

Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ

enthalten in: The Journal of infection | 2021

von Douxfils, J. | Gillot, C. | Mullier, F. | +1

CommentOn: J Infect. 2021 Jul 29;:null. - PMID 34332018

8

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

enthalten in: Viruses | 2021

von Favresse, J. | Gillot, C. | Di Chiaro, L. | +7

9

Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Favresse, J. | Elsen, M. | Eucher, C. | +6

1
[1]